Biotech: Pressemitteilungen - Kategorie - Seite 169

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Predicting the Future of IVF Using Past Performance as a Model

LIVINGSTON, NJ: LIVINGSTON, NJ -- (Marketwire) -- 11/19/12 -- In a new paper, published in Reproductive Biomedicine Online, Dr. Jacques Cohen of Althea and colleagues propose a projected timeline for achieving the u ...

Bio-Matrix' Regen BioPharma Initiates Pre-Clinical Study in Support of HemaXellerate(TM) Cell Therapy

SAN DIEGO, CA: Company Also Developing Two Solutions for Restoring Blood Production That Lack the Adverse Effects of Current Bone Marrow Stimulating Growth Factors ...

Miraculins Provides Year End Summary Report on PreVu Progress

WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwire) -- 11/19/12 -- Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk asse ...

Alnylam Pharmaceuticals, BioMarin Pharmaceutical Inc., and Cytonet Set to Speak on Conducting Effective Orphan Drug Research at marcus evans Conference

BOSTON, MA: Barbara Wuebbels, R.N., M.S., Oved Amitay, and Rod Monroy, Ph.D. Set to Speak at the Premier marcus evans Life Cycle of Orphan Drug Development & Commercialization Conference ...

TherapeuticMD Selects StayinFront

FAIRFIELD, NJ: StayinFront EdgeRx and StayinFront TouchRx to Be Deployed to Field Force and Management ...

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

NEW YORK, NY: Five Star Equities Provides Stock Research on MEI Pharma and Synergy Pharmaceuticals ...

Immunovaccine Announces Financial Results for the Quarter Ended September 30, 2012

HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwire) -- 11/16/12 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE: IMV), a clinical stage vaccine company developing the pate ...

Abattis Executes Bio-Pharma License Agreement with Vertical Designs Ltd.

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 11/15/12 -- Mr. Mike Withrow reportsAbattis Bioceuticals Corp. (CNSX: FLU) (the "Company" or "Abattis") is pleased to announce that ...

Dynavax Announces FDA Advisory Committee Meeting Outcome for HEPLISAV(TM)

BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 11/15/12 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products A ...

Cadus Reports Third Quarter 2012 Results

NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 11/15/12 -- (OTCQB: KDUS) announced yesterday its financial results for the third quarter ended September 30, 2012.Revenues for the three months ended September 30, 2 ...

The Alliance for Regenerative Medicine Elects Geoff MacKay as Next Chair, Welcomes New Officers and Executive Committee

WASHINGTON, DC: WASHINGTON, DC -- (Marketwire) -- 11/15/12 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the regenerative medicine community, announces the election of ...

Emerging World Pharma Inc. Strategic Partner African Global Pharma GH in Negotiations to Finalize Agreement for Sale and Distribution of Current Pharmaceutical Line

SUNYANI, GHANA: (OTC: EWPI) - Emerging World Pharma Inc. Strategic Partner African Global Pharma Corp. (AGP) Is Negotiating an Agreement to Distribute Our Full Line of Pharmaceutical Products to Several West African ...

Skystar Bio-Pharmaceutical Announces Results for Third Quarter Fiscal Year 2012

XI'AN, CHINA: Veterinary Medication Facility Resumes Production and Distribution; Veterinary Vaccine Facility Receives Initial GMP Certification ...

Peregrine Pharmaceuticals Announces Receipt of Notice From NASDAQ

TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 11/14/12 -- Peregrine Pharmaceuticals (NASDAQ: PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis ...

Tonix Pharmaceuticals Completes Convertible Note Offering

NEW YORK, NY: Capital From Board of Directors and Current Investors to Fund Further Development of TNX-102 SL to Treat Fibromyalgia and Post-Traumatic Stress Disorder ...

Boston Therapeutics Reports Third Quarter and Nine Months 2012 Financial Results

MANCHESTER, NH: MANCHESTER, NH -- (Marketwire) -- 11/14/12 -- Boston Therapeutics, Inc. (OTCQB: BTHE)SUGARDOWN® sales increased approximately 700% in the first nine months of 2012 compared with the same period in 2 ...

Prana Provides Huntington Disease Trial Update in Conjunction With the Huntington Study Group Annual Conference

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwire) -- 11/14/12 -- (NASDAQ: PRAN) (ASX: PBT) today reported on its progress in the Reach2HD trial, following a presentation by the Ms Dianne Angus, Prana's Chief ...

IsoRay, Inc. Reports First Quarter Results

RICHLAND, WA: Garnering New Cancer Treatment Revenues Remains the Strategy for Future Growth ...


Seite 169 von 255:  « ..  168 169 170  171  172  173  174  175  176  177  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z